Since the PERK-eIF2α pathway plays an important role in the drug resistance of cancer cells [81, 240], targeting the PERK-eIF2α pathway with chemotherapy is thought to be effective for cancer treatment and contributes to overcoming chemotherapy resistance (Fig. 4). Here, EIF2A is linked to cancer.